Join
Live feed
·
INSIDERFilingvia Quantisnow
Eledon Pharmaceuticals Inc. logo

Chief Executive Officer Gros David-Alexandre C was granted 354,454 shares and covered exercise/tax liability with 194,791 shares, increasing direct ownership by 1,774% to 168,663 units (SEC Form 4) (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELDN (Eledon Pharmaceuticals Inc.) and more on Quantisnow.